Hcw Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
HCWB Nasdaq 8731 https://hcwbiologics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hcw Biologics Inc

Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year - Feb 13th, 2023 10:21 am
HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago - Jan 3rd, 2023 12:50 pm
HCW Biologics Enters CRADA with National Cancer Institute - Dec 8th, 2022 12:55 pm
HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform - Dec 7th, 2022 12:30 pm
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting - Nov 8th, 2022 12:00 pm
HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights - Nov 7th, 2022 9:45 pm
Trade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Shares - Aug 28th, 2022 12:06 pm
HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights - Aug 12th, 2022 11:00 am
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology - Aug 3rd, 2022 11:15 am
HCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year ago - Jul 27th, 2022 11:56 am
Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth - Jun 27th, 2022 10:27 am
HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022 - May 23rd, 2022 11:30 am
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights - May 13th, 2022 11:15 am
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists - May 5th, 2022 11:30 am
HCW Biologics’ CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022 - Apr 19th, 2022 11:33 am
Favorable turn of events for HCW Biologics Inc. (NASDAQ:HCWB) insiders who've lost US$4.2m to date on a US$6.9m purchase - Apr 2nd, 2022 5:10 pm
HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021 - Mar 28th, 2022 11:00 am